Technical pitfalls and tips for the valve-in-valve procedure
Author:
Open Access
- 1 September 2017
- journal article
- research article
- Published by AME Publishing Company in Annals of Cardiothoracic Surgery
- Vol. 6 (5) , 541-552
Abstract
Transcatheter aortic valve implantation (TAVI) has emerged as a viable treatment modality for patients with severe aortic valve stenosis and multiple co-morbidities. More recent indications include the use of transcatheter heart valves (THV) to treat degenerated bioprosthetic surgical heart valves (SHV), which are failing due to stenosis or regurgitation. Valve-in-valve (VIV) procedures in the aortic position have been performed with a variety of THV devices, although the balloon-expandable SAPIEN valve platform (Edwards Lifesciences Ltd, Irvine, CA, USA) and self-expandable CoreValve platform (Medtronic Inc., MN, USA) have been used in majority of the patients. VIV treatment is appealing as it is less invasive than conventional surgery but optimal patient selection is vital to avoid complications such as malposition, residual high gradients and coronary obstruction. To minimize the risk of complications, thorough procedural planning is critical. The first step is identification of the degenerated SHV, including its model, size, fluoroscopic appearance. Although label size and stent internal diameter (ID) are provided by the manufacturer, it is important to note the true ID. The true ID is the ID of a SHV after the leaflets are mounted and helps determine the optimal size of THV. The second step is to determine the type and size of the THV. Although this is determined in the majority of the cases by user preference, in certain situations one THV may be more suitable than another. As the procedure is performed under fluoroscopy, the third step is to become familiarized with the fluoroscopic appearance of both the SHV and THV. This helps to determine the landmarks for optimal positioning, which in turn determines the gradients and fixation. The fourth step is to assess the risk of coronary obstruction. This is performed with either aortic root angiography or ECG-gated computerised tomography (CT). Finally, the route of approach must be carefully planned. Once these aspects are addressed, the procedure can be performed efficiently with a low risk of complications.Keywords
This publication has 19 references indexed in Scilit:
- Blood Stasis on Transcatheter Valve Leaflets and Implications for Valve-in-Valve Leaflet ThrombosisThe Annals of Thoracic Surgery, 2017
- Computed tomography assessment for transcatheter aortic valve in valve implantation: The vancouver approach to predict anatomical risk for coronary obstruction and other considerationsJournal of Cardiovascular Computed Tomography, 2016
- Valve-in-valve apps: why and how they were developed and how to use themEuroIntervention, 2014
- Use of balloon expandable transcatheter valves for valve-in-valve implantation in patients with degenerative stentless aortic bioprostheses: Technical considerations and resultsThe Journal of Thoracic and Cardiovascular Surgery, 2014
- Neo‐annulus: A reference plane in a surgical heart valve to facilitate a valve‐in‐valve procedureCatheterization and Cardiovascular Interventions, 2014
- Effect of Valve Design on the Stent Internal Diameter of a Bioprosthetic ValveJACC: Cardiovascular Interventions, 2014
- Transcatheter heart valve implantation for failing surgical bioprostheses: technical considerations and evidence for valve-in-valve proceduresHeart, 2013
- Aortic biological valve prosthesis in patients younger than 65 years of age: transition to a flexible age limit?Interactive CardioVascular and Thoracic Surgery, 2013
- Transcatheter Aortic Valve Implantation for the Treatment of Surgical Valve Dysfunction (“Valve-in-Valve”): Assessing the Risk of Coronary ObstructionJournal of Cardiac Surgery, 2012
- Percutaneous Transvenous Melody Valve-in-Ring Procedure for Mitral Valve ReplacementJACC, 2011